Loading...
Bleomycin — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Bleomycin
2025-Q4
Comprehensive analysis of India’s bleomycin export trade — suppliers, buyers, prices, routes, and every shipment record.
84
Shipments
$275K
Trade Value
43
Suppliers
36
Buyers
35
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/bleomycin
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s bleomycin trade — 2025-Q4
KEY TAKEAWAY
Bleomycin 2025-Q4 exports total $274.9K across 35 countries, with METINA PHARMACEUTICALS PVT LTD commanding 39.3% market share.
TOTAL SHIPMENTS
84
2025-Q4
EXPORT VALUE
$274.9K
FOB USD
TOTAL QUANTITY
41.2K
units shipped
INDIAN SUPPLIERS
43
unique exporters
GLOBAL BUYERS
36
unique importers
DESTINATIONS
35
countries
MEDIAN UNIT PRICE
$5.74
per unit
TOP-5 SHARE
84.7%
of total USD
BRANDED SHARE
66.7%
56 shipments
DOSAGE FORMS
7
product types
6 KEY FINDINGS
1
METINA PHARMACEUTICALS PVT LTD is India's #1 Bleomycin exporter with $108.0K (39.3% market share).→ §5, Indian Supplier Rankings
2
Bleomycin reached 35 countries, with Austria as the top destination ($108.0K).→ §4, Global Destination Map
3
Market concentration is moderate (HHI: 2412) — top 10 suppliers control 93.6% of exports.→ §5, Indian Supplier Rankings
4
94.4% of buyers (34 of 36) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
powder for solution dominates (50.9%) across 7 dosage forms.→ §7, Price Benchmarks
6
34 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 METINA PHARMACEUTICALS PVT LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian bleomycin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Bleomycin report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial bleomycin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian bleomycin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Bleomycin India trade report
Product scope
Bleomycin
All variants merged — branded and generic formulations of bleomycin
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
84
Every commercial bleomycin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $1.4K, Nov $242.2K, Dec $31.4K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$1.4K
Oct USD
3 shipments
2
$242.2K
Nov USD
+17806.8% MoM
3
$31.4K
Dec USD
-87.0% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 17806.8% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $275K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $241K rise in Nov, $211K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $1K | 3 shipments |
| Nov | $242K | 46 shipments |
| Dec | $31K | 35 shipments |
| Q4 Total | $275K | 84 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Myanmar held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: KHANDELWAL LABORATORIES PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import bleomycin from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Austria absorbs 39.3% of India’s 2025-Q4 bleomycin trade ($108.0K). Beyond the top 10 destinations, 34 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 16 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 34 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much bleomycin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$47K
17.0% of trade
10 countries · 36 shipments
Europe
$126K
45.7% of trade
4 countries · 4 shipments
Americas
$61K
22.2% of trade
5 countries · 9 shipments
Africa
$42K
15.1% of trade
16 countries · 35 shipments
Fig 4.1 Austria is the #1 corridor ($108K) — 30 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian bleomycin it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Austria | $108K | 1 | METINA PHARMACEUTICALS PVT LTD | $108K | — | — | — | — |
| 2 | Mexico | $41K | 3 | VENUS REMEDIES LTD | $41K | MYGENIC HEALTHCARE PVT LTD | $40 | — | — |
| 3 | Myanmar | $38K | 3 | KHANDELWAL LABORATORIES PVT LTD | $38K | — | — | — | — |
| 4 | Chile | $18K | 1 | VENUS REMEDIES LTD | $18K | — | — | — | — |
| 5 | Egypt | $14K | 3 | HEALTHBIOTICS PVT LTD | $8K | AARIA PHARMACEUTICALS PVT LTD | $6K | AL-ROYAL PHARMACEUTICAL PVT LTD | $56 |
| 6 | North Macedonia | $10K | 1 | VENUS REMEDIES LTD | $10K | — | — | — | — |
| 7 | Rwanda | $9K | 1 | PNT PHARMA | $9K | — | — | — | — |
| 8 | Madagascar | $7K | 5 | GETWELL PHARMA INDIA PVT LTD | $7K | — | — | — | — |
| 9 | Bosnia and Herzegovina | $4K | 1 | BRUCK PHARMA PVT LTD | $4K | — | — | — | — |
| 10 | Moldova | $4K | 1 | KWALITY PHARMACEUTICALS LTD | $4K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 17.0% of USD — but Austria is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
39.3%
#1 country share
Austria alone
79.8%
Top 5 share
5 of 35 countries
96.4%
Top 15 share
Long tail of 20 countries = 3.6%
HHI 2069
Destination HHI
Moderately concentrated
35
Countries served
Global pharma reach from India
16
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
43 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
METINA PHARMACEUTICALS PVT LTD ($108.0K, 39.3% share) and VENUS REMEDIES LTD ($69.1K) together control 64.4% of India’s 2025-Q4 bleomycin trade. The top 5 suppliers hold 84.7%. 43 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian bleomycin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 METINA PHARMACEUTICALS PVT LTD leads by $39K over VENUS REMEDIES LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: SANSKRUTI PHARMA is #19 by value but #4 by volume.
Fig 5.2 VENUS REMEDIES LTD also leads by shipment count (5) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: SANSKRUTI PHARMA moves from #4 by volume to #19 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 43 bleomycin suppliers split into strategic segments
KEY TAKEAWAY
11 suppliers (25%) generate 94.4% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 METINA PHARMACEUTICALS PVT LTD and VENUS REMEDIES LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 94.4% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | VENUS REMEDIES LTD | 4 | 4 | $69K |
| 2 | KHANDELWAL LABORATORIES PVT LTD | 3 | 2 | $38K |
| 3 | ZEAL PHARMA | 2 | 1 | $862 |
| 4 | METINA PHARMACEUTICALS PVT LTD | 1 | 1 | $108K |
| 5 | PNT PHARMA | 1 | 1 | $9K |
| 6 | HEALTHBIOTICS PVT LTD | 1 | 1 | $8K |
| 7 | GETWELL PHARMA INDIA PVT LTD | 1 | 1 | $7K |
| 8 | AARIA PHARMACEUTICALS PVT LTD | 1 | 1 | $6K |
| 9 | BRUCK PHARMA PVT LTD | 1 | 2 | $4K |
| 10 | KWALITY PHARMACEUTICALS LTD | 1 | 1 | $4K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the bleomycin manufacturing hubs
KEY TAKEAWAY
Navi Mumbai and Behra together account for $177K of India’s 2025-Q4 bleomycin trade.
Fig 5.5 Navi Mumbai (2 exporters, $108K) and Behra (1 exporters, $69K) are India’s bleomycin capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
84.7%
Top 5 share
5 of 43 suppliers
93.6%
Top 10 share
10 of 43 suppliers
94.4%
Top 25% share
11 suppliers = 94% USD
HHI 2412
Supplier HHI
Moderate
43
Total suppliers
shipped Bleomycin in 2025-Q4
20+ cities
Indian hubs
Navi Mumbai and Behra lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | VENUS REMEDIES LTD | $69K |
#2
2025-Q4 USD
$69K
25.1% market share
SHIPMENTS
5
avg $14K/ship
COUNTRIES
4
destination markets
BUYERS
4
4 single-sourced
BRANDED
0%
of shipments
DOSAGE FORMS
4
product types
TOP 4 DESTINATIONS
Mexico is the #1 market at $41K (59% of trade), followed by Chile at $18K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Mexico | $41K | 2 | 58.9% |
| 2 | Chile | $18K | 1 | 26.0% |
| 3 | North Macedonia | $10K | 1 | 14.1% |
| 4 | Bahamas | $666 | 1 | 1.0% |
MONTHLY TREND
Nov peaked at $69K. Oct was the weakest at $0.
PRODUCT MIX
powder for solution dominates at 46% of trade. Powder (40.1%) and Injection are secondary formulations.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| U T S D C | Mexico | $41K | ⚠ Locked |
| F X S | Chile | $18K | ⚠ Locked |
| P D I E | North Macedonia | $10K | ⚠ Locked |
| M O H | Bahamas | $666 | ⚠ Locked |
#2
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
VENUS REMEDIES LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P1.3 Mexico absorbs $41K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
36 importers across 35 countries — who is buying Indian bleomycin and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 45.0% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian bleomycin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 U T S D C is the #1 importer at $41K (14.8%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
94%
Single-source
34 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
6%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source bleomycin from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United Arab Emirates 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| FOR THE ORDER OF | 3S CORP | $968.616 | $5.381 | Injection |
| MEDIMART DRUG STORE | DROPS PHARMA PVT LTD | $587.643 | $3.918 | Injection |
| BEST INTERNATIONAL FZE | MEDEX PHARMACEUTICALS | $574.955 | $7.187 | Injection |
| ZMC EXPRESS CARGO FZCO | HUMANKIND PHARMA | $84.006 | $0.849 | Injection |
| TO THE PURCHASE MANAGE… | REGALIA LIFE SCIENCE… | $5.358 | $0.357 | Vial |
Madagascar 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| CENTRALE DACHATS DE ME… | GETWELL PHARMA INDIA… | $7K | $9.064 | Injection |
| HANITRA RAZAOARIMANANA | GETWELL PHARMA INDIA… | $0.865 | $0.216 | Injection |
Brazil 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| HELENA SIQUEIRA PIROVANI | NIVIRA EXPORTS | $740.000 | $7.400 | Injection |
| EMANUELLE GAMA RIBEIRO… | NIVIRA EXPORTS | $740.000 | $7.400 | Injection |
Lebanon 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| DRUGSTORE 3U S.A | NEON LABORATORIES LTD | $216.058 | $0.054 | Injection |
| EXPTRANS GMBH | NEON LABORATORIES LTD | $2.938 | $0.095 | Injection |
Ghana 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PSG EXPRESS LINK LTD | PREMIER ENTERPRISE | $99.886 | $9.989 | Injection |
| AS PER INVOICE GHANA | VAMA HEALTH WORLD LLP | $0.992 | $0.083 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | U T S D C | Mexico | $41K | $20K | Mid |
| 2 | NI LAY NAING CO LTD | Myanmar | $24K | $12K | Budget |
| 3 | F X S | Chile | $18K | $18K | Mid |
| 4 | P D I E | North Macedonia | $10K | $10K | Budget |
| 5 | TO THE | Rwanda | $9K | $9K | Budget |
| 6 | CENTRALE DACHATS DE … | Madagascar | $7K | $2K | Budget |
| 7 | DITA ESTFARM LLC | Moldova | $4K | $4K | Budget |
| 8 | DOMAKS INVESTMENT LTD | Nigeria | $2K | $923.000 | Budget |
| 9 | TRIDENT HEALTHCARE LTD | Mauritius | $1K | $1K | Budget |
| 10 | FOR THE ORDER OF | United Arab Emirates | $968.616 | $323.000 | Budget |
| 11 | HELENA SIQUEIRA PIRO… | Brazil | $740.000 | $740.000 | Budget |
| 12 | EMANUELLE GAMA RIBEI… | Brazil | $740.000 | $740.000 | Budget |
| 13 | HEALTH CARE AGENCY | Seychelles | $700.694 | $701.000 | Budget |
| 14 | DALIAN CHAOHONGSUPPL… | China | $674.620 | $675.000 | Budget |
| 15 | M O H | Bahamas | $665.532 | $666.000 | Budget |
| 16 | MEDIMART DRUG STORE | United Arab Emirates | $587.643 | $588.000 | Budget |
| 17 | BEST INTERNATIONAL FZE | United Arab Emirates | $574.955 | $192.000 | Budget |
| 18 | PHARMACHEIME LTD | Malawi | $543.337 | $543.000 | Budget |
| 19 | CENTRAIMED | Equatorial Guinea | $357.987 | $358.000 | Budget |
| 20 | RADEEP SERVICES | Singapore | $317.356 | $317.000 | Budget |
| 21 | SALAMA NIGERIA LTD | Benin | $287.174 | $287.000 | Budget |
| 22 | CLYZ PHARMA SARL | Cameroon | $280.481 | $280.000 | Budget |
| 23 | DRUGSTORE 3U S.A | Lebanon | $216.058 | $108.000 | Budget |
| 24 | PSG EXPRESS LINK LTD | Ghana | $99.886 | $100.000 | Budget |
| 25 | STATE TRADING ORGANI… | Maldives | $90.060 | $90.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 METINA PHARMACEUTICALS PVT LTD → U T S D C is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian bleomycin prices vary by supplier, country and dosage form
KEY TAKEAWAY
Bleomycin prices span 773× ($0.028 → $21.65). The coefficient of variation is 0.68. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.028 | Lowest observed unit price |
| P5 | $0.082 | 5th percentile |
| P25 | $4.93 | 25th percentile (Q1) |
| Median | $5.74 | 50th percentile (Q2) |
| P75 | $7.69 | 75th percentile (Q3) |
| P95 | $10.58 | 95th percentile |
| Max | $21.65 | Highest observed unit price |
| Mean | $6.20 | Arithmetic average |
| CV | 68% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 SMITS HEALTHCARE prices at $20.83/unit vs market median $5.74.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. KHANDELWAL LABORATORIES PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. VENUS REMEDIES LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. PNT PHARMA Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. METINA PHARMACEUTICALS PVT Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | VENUS REMEDIES LTD | North Macedonia | Powder | 450 | $10K | $21.65 | Specialty / small-batch |
| Dec 2025 | SMITS HEALTHCARE | Mauritius | Injection | 60 | $1K | $20.83 | Sterile formulation premium |
| Nov 2025 | METINA PHARMACEU… | Austria | powder for solution | 6K | $108K | $19.27 | Specialty / small-batch |
| Dec 2025 | DM WORLDWIDE TRA… | Cote d'Ivoire | Injection | 10 | $156.75 | $15.68 | Sterile formulation premium |
| Nov 2025 | G P INTERGLOBE | Seychelles | Injection | 70 | $700.69 | $10.01 | Sterile formulation premium |
| Nov 2025 | PREMIER ENTERPRISE | Ghana | Injection | 10 | $99.89 | $9.99 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 20 | $197.93 | $9.90 | Sterile formulation premium |
| Dec 2025 | BRUCK PHARMA PVT… | Bosnia and Herzegovina | Injection | 437 | $4K | $9.76 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 20 | $190.30 | $9.52 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 20 | $190.30 | $9.52 | Sterile formulation premium |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 100 | $2.80 | $0.028 | Sterile formulation premium |
| Dec 2025 | AL-ROYAL PHARMAC… | Egypt | Injection | 1K | $56.37 | $0.056 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 300 | $17.77 | $0.059 | Sterile formulation premium |
| Dec 2025 | MYGENIC HEALTHCA… | Mexico | Injection | 500 | $39.86 | $0.080 | Sterile formulation premium |
| Dec 2025 | VAMA HEALTH WORL… | Ghana | Injection | 12 | $0.992 | $0.083 | Sterile formulation premium |
| Dec 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 20 | $1.72 | $0.086 | Sterile formulation premium |
| Dec 2025 | MEDYRA PHARMACEU… | Cameroon | Injection | 50 | $4.43 | $0.089 | Sterile formulation premium |
| Dec 2025 | MATU INTERNATION… | Eritrea | Injection | 100 | $9.26 | $0.093 | Sterile formulation premium |
| Dec 2025 | NEON LABORATORIE… | Lebanon | Injection | 30 | $2.82 | $0.094 | Sterile formulation premium |
| Dec 2025 | NEON LABORATORIE… | Lebanon | Injection | 2K | $216.06 | $0.108 | Sterile formulation premium |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship bleomycin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Bleomycin leaves India through 7+ ports. The top 5 (MUMBAI AIR (SAHAR), DELHI AIR, AHMEDABAD AIR) handle 99.9% of total USD. AIR moves 95% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUMBAI AIR (SAHAR) handles $179K — top 7 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 VIENNA is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 95% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$274K
99.7% of USD · 95.2% of ships
SEA
$891
0.3% of USD · 4.8% of ships
Fig 8.3 The dominant corridor is MUMBAI AIR (SAHAR) → Air → Europe ($112K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Madagascar is the most concentrated destination (HHI 10000, 1 suppliers). United Arab Emirates is the most competitive (HHI 3117).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Madagascar (HHI 10,000) is the most concentrated — United Arab Emirates (HHI 3,117) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| U T S D C | Mexico | VENUS REMEDIES LTD | $41K | 2 | MEDIUM |
| NI LAY NAING CO LTD | Myanmar | KHANDELWAL LABOR… | $24K | 2 | MEDIUM |
| F X S | Chile | VENUS REMEDIES LTD | $18K | 1 | MEDIUM |
| P D I E | North Macedonia | VENUS REMEDIES LTD | $10K | 1 | MEDIUM |
| TO THE | Rwanda | PNT PHARMA | $9K | 1 | MEDIUM |
| CENTRALE DACHATS DE … | Madagascar | GETWELL PHARMA I… | $7K | 4 | MEDIUM |
| DITA ESTFARM LLC | Moldova | KWALITY PHARMACE… | $4K | 1 | MEDIUM |
| DOMAKS INVESTMENT LTD | Nigeria | ZUVIUS LIFESCIEN… | $2K | 2 | MEDIUM |
Conclusion: 34 buyers depend on exactly one Indian supplier, representing $124K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Austria | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mexico | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Chile | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Egypt | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| North Macedonia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Rwanda | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Madagascar | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Bosnia and Herzegovina | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Moldova | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Tajikistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Mexico | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Madagascar lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Austria (1 suppliers) | This Q | HIGH |
| A6 | Enter Mexico (2 suppliers) | This Q | MED |
| A8 | Build Mexico distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Austria tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Austria | Other | 1 | $108K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Mexico | Other | 2 | $41K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Myanmar | Asia | 1 | $38K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Chile | Other | 1 | $18K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Egypt | Africa | 3 | $14K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 6 | North Macedonia | Other | 1 | $10K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Rwanda | Africa | 1 | $9K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Madagascar | Africa | 1 | $7K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Bosnia and Herzegovina | Other | 1 | $4K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Moldova | Other | 1 | $4K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Nigeria | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Kenya | Africa | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Brazil | Other | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Tajikistan | Asia | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Mauritius | Africa | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 84 2025-Q4 Bleomycin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/bleomycin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 84 2025-Q4 bleomycin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian bleomycin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
84
across all regions
TOTAL USD
$275K
2025-Q4 FOB value
UNITS
41.2K
tablets, capsules, etc.
SUPPLIERS
43
Indian exporters
BUYERS
36
global importers
COUNTRIES
35
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $42K (15.1%), spanning 16 countries.
43 Indian suppliers shipped to 36 buyers across 35 countries — average shipment value $3K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
16 countries · 35 shipments · $42K · 22 Indian suppliers · 15 buyers
SHIPMENTS
35
USD
$42K
COUNTRIES
16
SUPPLIERS
22
BUYERS
15
HHI
1,503
moderate
Top 16 destination countries in Africa
1
Egypt (34.0%)
$14K
2
Rwanda (22.9%)
$9K
3
Madagascar (17.5%)
$7K
4
Nigeria (6.8%)
$3K
5
Kenya (5.5%)
$2K
6
Mauritius (3.0%)
$1K
7
Cameroon (2.8%)
$1K
8
Burkina Faso (1.9%)
$770.54
9
Seychelles (1.7%)
$700.69
10
Malawi (1.3%)
$543.34
11
Equatorial Guinea (0.9%)
$357.99
12
Benin (0.7%)
$287.17
13
Ghana (0.5%)
$192.72
14
Burundi (0.4%)
$170.80
15
Cote d'Ivoire (0.4%)
$156.75
16
Eritrea (0.0%)
$9.26
Top 22 Indian suppliers into Africa
1
PNT PHARMA
$9K
2
HEALTHBIOTICS PVT LTD
$8K
3
GETWELL PHARMA INDIA PVT LTD
$7K
4
AARIA PHARMACEUTICALS PVT LTD
$6K
5
ZUVIUS LIFESCIENCES PVT LTD
$3K
6
SUBHRA PHARMA PRIAVATE LTD
$2K
7
SMITS HEALTHCARE
$1K
8
NEOPHAR PHARMACEUTICALS PVT LTD
$870.10
9
SANSKRUTI PHARMA
$770.54
10
G P INTERGLOBE
$700.69
11
MATHI ASSOCIATES
$543.34
12
PIRZE LIFECARE PVT LTD
$357.99
13
ZAHIDI ENTERPRISE
$287.17
14
RUN MEDWAY
$280.48
15
BRUCK PHARMA PVT LTD
$170.80
16
DM WORLDWIDE TRADING
$156.75
17
PREMIER ENTERPRISE
$99.89
18
RUTVA MEDICARE
$91.84
19
AL-ROYAL PHARMACEUTICAL PVT LTD
$56.37
20
MATU INTERNATIONAL PVT LTD
$9.26
21
MEDYRA PHARMACEUTICAL
$4.43
22
VAMA HEALTH WORLD LLP
$0.992
Top 13 Africa importers
1
TO THE · Rwanda
$9K
2
CENTRALE DACHATS DE MEDICAMENTS · Madagascar
$7K
3
DOMAKS INVESTMENT LTD · Nigeria
$2K
4
TRIDENT HEALTHCARE LTD · Mauritius
$1K
5
HEALTH CARE AGENCY · Seychelles
$700.69
6
PHARMACHEIME LTD · Malawi
$543.34
7
CENTRAIMED · Equatorial Guinea
$357.99
8
SALAMA NIGERIA LTD · Benin
$287.17
9
CLYZ PHARMA SARL · Cameroon
$280.48
10
PSG EXPRESS LINK LTD · Ghana
$99.89
11
ROYAL PHARMA COMPANY · Egypt
$56.37
12
AS PER INVOICE GHANA · Ghana
$0.992
13
HANITRA RAZAOARIMANANA · Madagascar
$0.865
Top 3 dosage forms
1
Injection
$39K
2
Vial
$2K
3
Unknown
$449.83
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 18 | $27K | $1K |
| Dec | 17 | $15K | $855.39 |
Shipment register · 35 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — PNT PHARMA · 1 shipments · $9K | |||||||||||
| 1 | Dec 2025 | TO THE | Rwanda | Injection | 1.6K | VLS | $5.93 | $9K | MUMBAI AIR (SAHAR) | KIGALI - | AIR |
| SUPPLIER #2 — HEALTHBIOTICS PVT LTD · 1 shipments · $8K | |||||||||||
| 2 | Nov 2025 | UNKNOWN BUYER | Egypt | Injection | 1.5K | NOS | $5.09 | $8K | AHMEDABAD AIR | ALEXANDRIA, EL NHOUZ | AIR |
| SUPPLIER #3 — GETWELL PHARMA INDIA PVT LTD · 5 shipments · $7K | |||||||||||
| 3 | Nov 2025 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | Injection | 340 | NOS | $9.40 | $3K | DELHI AIR | ANTANANARIVO | AIR |
| 4 | Nov 2025 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | Injection | 60 | NOS | $9.40 | $564.00 | DELHI AIR | ANTANANARIVO | AIR |
| 5 | Nov 2025 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | Injection | 340 | NOS | $8.73 | $3K | DELHI AIR | ANTANANARIVO | AIR |
| 6 | Nov 2025 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | Injection | 60 | NOS | $8.73 | $523.71 | DELHI AIR | ANTANANARIVO | AIR |
| 7 | Nov 2025 | HANITRA RAZAOARIMANANA | Madagascar | Injection | 4 | NOS | $0.216 | $0.865 | DELHI AIR | ANTANANARIVO | AIR |
| SUPPLIER #4 — AARIA PHARMACEUTICALS PVT LTD · 1 shipments · $6K | |||||||||||
| 8 | Nov 2025 | UNLISTED BUYER | Egypt | Injection | 1.2K | NOS | $5.34 | $6K | MUMBAI AIR (SAHAR) | ALEXANDRIA, EL NHOUZ | AIR |
| SUPPLIER #5 — ZUVIUS LIFESCIENCES PVT LTD · 3 shipments · $3K | |||||||||||
| 9 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 150 | NOS | $6.42 | $962.46 | DELHI AIR | LAGOS | AIR |
| 10 | Nov 2025 | UNKNOWN BUYER | Nigeria | Injection | 150 | NOS | $6.42 | $962.46 | DELHI AIR | LAGOS | AIR |
| 11 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 150 | NOS | $5.89 | $883.83 | DELHI AIR | LAGOS | AIR |
| SUPPLIER #6 — SUBHRA PHARMA PRIAVATE LTD · 4 shipments · $2K | |||||||||||
| 12 | Nov 2025 | UNLISTED BUYER | Kenya | Vial | 150 | NOS | $5.06 | $759.39 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 150 | NOS | $5.07 | $760.25 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 150 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 150 | NOS | $5.01 | $752.08 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #7 — SMITS HEALTHCARE · 1 shipments · $1K | |||||||||||
| 16 | Dec 2025 | TRIDENT HEALTHCARE LTD | Mauritius | Injection | 60 | NOS | $20.83 | $1K | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #8 — NEOPHAR PHARMACEUTICALS PVT LTD · 1 shipments · $870.10 | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Cameroon | Injection | 126 | VLS | $6.91 | $870.10 | DELHI AIR | DOUALA | AIR |
| SUPPLIER #9 — SANSKRUTI PHARMA · 5 shipments · $770.54 | |||||||||||
| 18 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 20 | VLS | $9.90 | $197.93 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 19 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 20 | VLS | $9.52 | $190.30 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 20 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Injection | 20 | VLS | $9.52 | $190.30 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 21 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 20 | VLS | $9.51 | $190.29 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 22 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Injection | 20 | VLS | $0.086 | $1.72 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #10 — G P INTERGLOBE · 1 shipments · $700.69 | |||||||||||
| 23 | Nov 2025 | HEALTH CARE AGENCY | Seychelles | Injection | 70 | NOS | $10.01 | $700.69 | DELHI AIR | MAHE ISLAND | AIR |
| SUPPLIER #11 — MATHI ASSOCIATES · 1 shipments · $543.34 | |||||||||||
| 24 | Nov 2025 | PHARMACHEIME LTD | Malawi | Injection | 100 | VLS | $5.43 | $543.34 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| SUPPLIER #12 — PIRZE LIFECARE PVT LTD · 1 shipments · $357.99 | |||||||||||
| 25 | Dec 2025 | CENTRAIMED | Equatorial Guinea | 50 | NOS | $7.16 | $357.99 | AHMEDABAD AIR | MALABO | AIR | |
| SUPPLIER #13 — ZAHIDI ENTERPRISE · 1 shipments · $287.17 | |||||||||||
| 26 | Dec 2025 | SALAMA NIGERIA LTD | Benin | Injection | 50 | NOS | $5.74 | $287.17 | MUMBAI AIR (SAHAR) | COTONOU | AIR |
| SUPPLIER #14 — RUN MEDWAY · 1 shipments · $280.48 | |||||||||||
| 27 | Dec 2025 | CLYZ PHARMA SARL | Cameroon | Injection | 50 | NOS | $5.61 | $280.48 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #15 — BRUCK PHARMA PVT LTD · 1 shipments · $170.80 | |||||||||||
| 28 | Dec 2025 | UNLISTED BUYER | Burundi | Injection | 20 | NOS | $8.54 | $170.80 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| SUPPLIER #16 — DM WORLDWIDE TRADING · 1 shipments · $156.75 | |||||||||||
| 29 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Injection | 10 | NOS | $15.68 | $156.75 | AHMEDABAD AIR | ABIDJAN | AIR |
| SUPPLIER #17 — PREMIER ENTERPRISE · 1 shipments · $99.89 | |||||||||||
| 30 | Nov 2025 | PSG EXPRESS LINK LTD | Ghana | Injection | 10 | NOS | $9.99 | $99.89 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #18 — RUTVA MEDICARE · 1 shipments · $91.84 | |||||||||||
| 31 | Dec 2025 | UNLISTED BUYER | Ghana | 20 | PCS | $4.59 | $91.84 | AHMEDABAD AIR | ACCRA | AIR | |
| SUPPLIER #19 — AL-ROYAL PHARMACEUTICAL PVT LTD · 1 shipments · $56.37 | |||||||||||
| 32 | Dec 2025 | ROYAL PHARMA COMPANY | Egypt | Injection | 1.0K | NOS | $0.056 | $56.37 | DELHI AIR | ALEXANDRIA, EL NHOUZ | AIR |
| SUPPLIER #20 — MATU INTERNATIONAL PVT LTD · 1 shipments · $9.26 | |||||||||||
| 33 | Dec 2025 | UNLISTED BUYER | Eritrea | Injection | 100 | NOS | $0.093 | $9.26 | DELHI AIR | ASMARA | AIR |
| SUPPLIER #21 — MEDYRA PHARMACEUTICAL · 1 shipments · $4.43 | |||||||||||
| 34 | Dec 2025 | UNLISTED BUYER | Cameroon | Injection | 50 | NOS | $0.089 | $4.43 | DELHI AIR | DOUALA | AIR |
| SUPPLIER #22 — VAMA HEALTH WORLD LLP · 1 shipments · $0.992 | |||||||||||
| 35 | Dec 2025 | AS PER INVOICE GHANA | Ghana | Injection | 12 | NOS | $0.083 | $0.992 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
10 countries · 36 shipments · $47K · 15 Indian suppliers · 15 buyers
SHIPMENTS
36
USD
$47K
COUNTRIES
10
SUPPLIERS
15
BUYERS
15
HHI
6,824
concentrated
Top 10 destination countries in Asia
1
Myanmar (82.4%)
$38K
2
United Arab Emirates (7.5%)
$3K
3
Tajikistan (2.8%)
$1K
4
Lebanon (2.2%)
$1K
5
Iraq (1.8%)
$862.31
6
China (1.4%)
$674.62
7
Singapore (0.7%)
$317.36
8
Turkey (0.6%)
$283.56
9
Cambodia (0.3%)
$152.83
10
Maldives (0.2%)
$90.06
Top 15 Indian suppliers into Asia
1
KHANDELWAL LABORATORIES PVT LTD
$38K
2
3S CORP
$2K
3
RMPL PHARMA LLP
$2K
4
GALAXY SUPER SPECIALITY
$1K
5
ZEAL PHARMA
$862.31
6
MEDEX PHARMACEUTICALS
$716.71
7
JMB PHARMACEUTICALS PVT LTD
$674.62
8
DROPS PHARMA PVT LTD
$587.64
9
PHARMA CHOICE LLP
$317.36
10
NEON LABORATORIES LTD
$219.00
11
VANDAN HEALTHCARE
$152.83
12
MC PHARMA DISTRIBUTORS
$90.06
13
HUMANKIND PHARMA
$84.01
14
AMARI TRADE ALLIANCE LLP
$20.58
15
REGALIA LIFE SCIENCE PVT LTD
$5.36
Top 13 Asia importers
1
NI LAY NAING CO LTD · Myanmar
$24K
2
FOR THE ORDER OF · United Arab Emirates
$968.62
3
DALIAN CHAOHONGSUPPLY CHAIN MANAGEM · China
$674.62
4
MEDIMART DRUG STORE · United Arab Emirates
$587.64
5
BEST INTERNATIONAL FZE · United Arab Emirates
$574.95
6
RADEEP SERVICES · Singapore
$317.36
7
DRUGSTORE 3U S.A · Lebanon
$216.06
8
STATE TRADING ORGANIZATION PLC · Maldives
$90.06
9
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$84.01
10
ABU ABDU · Turkey
$20.58
11
TO THE PURCHASE MANAGER IMPORT DEPA · United Arab Emirates
$5.36
12
EXPTRANS GMBH · Lebanon
$2.94
13
MEDITERRENEAN PHARMACEUTICAL · Lebanon
$0.0000
Top 4 dosage forms
1
Injection
$37K
2
Vial
$9K
3
Other
$299.87
4
lyophilized powder
$0.0000
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $1K | $450.77 |
| Nov | 19 | $34K | $2K |
| Dec | 14 | $11K | $790.29 |
Shipment register · 36 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — KHANDELWAL LABORATORIES PVT LTD · 4 shipments · $38K | |||||||||||
| 1 | Nov 2025 | NI LAY NAING CO LTD | Myanmar | Injection | 3.0K | VLS | $4.85 | $15K | MUMBAI AIR (SAHAR) | YANGON | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | Myanmar | Injection | 3.0K | VLS | $4.85 | $15K | MUMBAI AIR (SAHAR) | YANGON | AIR |
| 3 | Dec 2025 | MEDITERRENEAN PHARMACEUTICAL | Lebanon | lyophilized powder | 3.0K | VLS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 4 | Dec 2025 | NI LAY NAING CO LTD | Myanmar | Vial | 2.0K | VLS | $4.68 | $9K | MUMBAI AIR (SAHAR) | YANGON | AIR |
| SUPPLIER #2 — 3S CORP · 5 shipments · $2K | |||||||||||
| 5 | Nov 2025 | FOR THE ORDER OF | United Arab Emirates | Injection | 60 | VLS | $5.72 | $343.24 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 6 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 60 | VLS | $5.72 | $343.24 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 7 | Nov 2025 | FOR THE ORDER OF | United Arab Emirates | Injection | 60 | VLS | $5.72 | $343.24 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 8 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 60 | VLS | $5.72 | $343.24 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 9 | Nov 2025 | FOR THE ORDER OF | United Arab Emirates | Injection | 60 | VLS | $4.70 | $282.13 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| SUPPLIER #3 — RMPL PHARMA LLP · 4 shipments · $2K | |||||||||||
| 10 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 40 | NOS | $5.55 | $222.06 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 11 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 40 | NOS | $5.55 | $222.06 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 12 | Dec 2025 | UNLISTED BUYER | Lebanon | Injection | 150 | NOS | $5.50 | $824.92 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Turkey | Injection | 50 | NOS | $5.26 | $262.98 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #4 — GALAXY SUPER SPECIALITY · 1 shipments · $1K | |||||||||||
| 14 | Nov 2025 | UNLISTED BUYER | Tajikistan | Injection | 200 | NOS | $6.64 | $1K | DELHI AIR | TASHKENT | AIR |
| SUPPLIER #5 — ZEAL PHARMA · 3 shipments · $862.31 | |||||||||||
| 15 | Nov 2025 | UNLISTED BUYER | Iraq | Injection | 50 | NOS | $5.62 | $281.22 | MUMBAI AIR (SAHAR) | BAGDAD, METROPOLITAN | AIR |
| 16 | Nov 2025 | UNLISTED BUYER | Iraq | Other | 50 | NOS | $6.00 | $299.87 | MUMBAI AIR (SAHAR) | BAGDAD, METROPOLITAN | AIR |
| 17 | Nov 2025 | UNLISTED BUYER | Iraq | Injection | 50 | NOS | $5.62 | $281.22 | MUMBAI AIR (SAHAR) | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #6 — MEDEX PHARMACEUTICALS · 4 shipments · $716.71 | |||||||||||
| 18 | Nov 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 20 | NOS | $7.09 | $141.76 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 19 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 20 | NOS | $7.09 | $141.76 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 20 | Nov 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 10 | NOS | $7.09 | $70.92 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 21 | Dec 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 50 | NOS | $7.25 | $362.28 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #7 — JMB PHARMACEUTICALS PVT LTD · 3 shipments · $674.62 | |||||||||||
| 22 | Oct 2025 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | Injection | 100 | NOS | $6.75 | $674.62 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 23 | Dec 2025 | UNLISTED BUYER | China | Injection | 100 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 24 | Dec 2025 | UNLISTED BUYER | China | Injection | 100 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| SUPPLIER #8 — DROPS PHARMA PVT LTD · 1 shipments · $587.64 | |||||||||||
| 25 | Oct 2025 | MEDIMART DRUG STORE | United Arab Emirates | Injection | 150 | NOS | $3.92 | $587.64 | COCHIN SEA | DUBAI | AIR |
| SUPPLIER #9 — PHARMA CHOICE LLP · 1 shipments · $317.36 | |||||||||||
| 26 | Nov 2025 | RADEEP SERVICES | Singapore | Injection | 60 | NOS | $5.29 | $317.36 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #10 — NEON LABORATORIES LTD · 4 shipments · $219.00 | |||||||||||
| 27 | Dec 2025 | EXPTRANS GMBH | Lebanon | Injection | 30 | NOS | $0.094 | $2.82 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 28 | Dec 2025 | EXPTRANS GMBH | Lebanon | Vial | 1 | NOS | $0.118 | $0.118 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 29 | Dec 2025 | DRUGSTORE 3U S.A | Lebanon | Injection | 2.0K | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 30 | Dec 2025 | DRUGSTORE 3U S.A | Lebanon | Injection | 2.0K | NOS | $0.108 | $216.06 | MUMBAI AIR (SAHAR) | BEIRUT | SEA |
| SUPPLIER #11 — VANDAN HEALTHCARE · 1 shipments · $152.83 | |||||||||||
| 31 | Nov 2025 | UNLISTED BUYER | Cambodia | Injection | 30 | NOS | $5.09 | $152.83 | AHMEDABAD AIR | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #12 — MC PHARMA DISTRIBUTORS · 1 shipments · $90.06 | |||||||||||
| 32 | Oct 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Injection | 14 | PCS | $6.43 | $90.06 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #13 — HUMANKIND PHARMA · 1 shipments · $84.01 | |||||||||||
| 33 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Injection | 99 | NOS | $0.849 | $84.01 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| SUPPLIER #14 — AMARI TRADE ALLIANCE LLP · 2 shipments · $20.58 | |||||||||||
| 34 | Dec 2025 | ABU ABDU | Turkey | Injection | 100 | NOS | $0.028 | $2.80 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 35 | Dec 2025 | ABU ABDU | Turkey | Injection | 300 | NOS | $0.059 | $17.77 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #15 — REGALIA LIFE SCIENCE PVT LTD · 1 shipments · $5.36 | |||||||||||
| 36 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Vial | 15 | NOS | $0.357 | $5.36 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
4 countries · 4 shipments · $126K · 4 Indian suppliers · 3 buyers
SHIPMENTS
4
USD
$126K
COUNTRIES
4
SUPPLIERS
4
BUYERS
3
HHI
7,477
concentrated
Top 4 destination countries in Europe
1
Austria (86.0%)
$108K
2
North Macedonia (7.8%)
$10K
3
Bosnia and Herzegovina (3.4%)
$4K
4
Moldova (2.8%)
$4K
Top 4 Indian suppliers into Europe
1
METINA PHARMACEUTICALS PVT LTD
$108K
2
VENUS REMEDIES LTD
$10K
3
BRUCK PHARMA PVT LTD
$4K
4
KWALITY PHARMACEUTICALS LTD
$4K
Top 2 Europe importers
1
P D I E · North Macedonia
$10K
2
DITA ESTFARM LLC · Moldova
$4K
Top 3 dosage forms
1
powder for solution
$108K
2
Powder
$10K
3
Injection
$8K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 3 | $121K | $40K |
| Dec | 1 | $4K | $4K |
Shipment register · 4 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — METINA PHARMACEUTICALS PVT LTD · 1 shipments · $108K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Austria | powder for solution | 5.6K | VLS | $19.27 | $108K | MUMBAI AIR (SAHAR) | VIENNA | AIR |
| SUPPLIER #2 — VENUS REMEDIES LTD · 1 shipments · $10K | |||||||||||
| 2 | Nov 2025 | P D I E | North Macedonia | Powder | 450 | VLS | $21.65 | $10K | DELHI AIR | SKOPJE | AIR |
| SUPPLIER #3 — BRUCK PHARMA PVT LTD · 1 shipments · $4K | |||||||||||
| 3 | Dec 2025 | UNLISTED BUYER | Bosnia and Herzegovina | Injection | 437 | NOS | $9.76 | $4K | MUMBAI AIR (SAHAR) | SARAJEVO | AIR |
| SUPPLIER #4 — KWALITY PHARMACEUTICALS LTD · 1 shipments · $4K | |||||||||||
| 4 | Nov 2025 | DITA ESTFARM LLC | Moldova | Injection | 600 | NOS | $5.94 | $4K | DELHI AIR | CHISINAU | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
5 countries · 9 shipments · $61K · 4 Indian suppliers · 8 buyers
SHIPMENTS
9
USD
$61K
COUNTRIES
5
SUPPLIERS
4
BUYERS
8
HHI
9,463
concentrated
Top 5 destination countries in Americas
1
Mexico (66.8%)
$41K
2
Chile (29.5%)
$18K
3
Brazil (2.4%)
$1K
4
Bahamas (1.1%)
$665.53
5
Saint Kitts and Nevis (0.3%)
$159.73
Top 4 Indian suppliers into Americas
1
VENUS REMEDIES LTD
$59K
2
NIVIRA EXPORTS
$1K
3
SPR ONCOCARE PVT LTD
$159.73
4
MYGENIC HEALTHCARE PVT LTD
$39.86
Top 6 Americas importers
1
U T S D C · Mexico
$41K
2
F X S · Chile
$18K
3
HELENA SIQUEIRA PIROVANI · Brazil
$740.00
4
EMANUELLE GAMA RIBEIRO DO VALLE · Brazil
$740.00
5
M O H · Bahamas
$665.53
6
WELLPOINT MEDICAL & ONCOLOGY CENTER · Saint Kitts and Nevis
$79.86
Top 5 dosage forms
1
powder for solution
$32K
2
Powder
$18K
3
Injection
$10K
4
powder for solution for injection
$665.53
5
Unknown
$79.86
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 6 | $60K | $10K |
| Dec | 3 | $2K | $506.62 |
Shipment register · 9 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — VENUS REMEDIES LTD · 4 shipments · $59K | |||||||||||
| 1 | Nov 2025 | F X S | Chile | Powder | 2.1K | VLS | $8.49 | $18K | DELHI AIR | SANTIAGO DE CHILE - | AIR |
| 2 | Nov 2025 | U T S D C | Mexico | powder for solution | 4.7K | VLS | $6.73 | $32K | DELHI AIR | GUADALAJARA | AIR |
| 3 | Nov 2025 | U T S D C | Mexico | Injection | 1.3K | VLS | $6.73 | $9K | DELHI AIR | GUADALAJARA | AIR |
| 4 | Nov 2025 | M O H | Bahamas | powder for solution for injection | 72 | VLS | $9.24 | $665.53 | DELHI AIR | NASSAU | AIR |
| SUPPLIER #2 — NIVIRA EXPORTS · 2 shipments · $1K | |||||||||||
| 5 | Dec 2025 | HELENA SIQUEIRA PIROVANI | Brazil | Injection | 100 | SET | $7.40 | $740.00 | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
| 6 | Dec 2025 | EMANUELLE GAMA RIBEIRO DO VALLE | Brazil | Injection | 100 | SET | $7.40 | $740.00 | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
| SUPPLIER #3 — SPR ONCOCARE PVT LTD · 2 shipments · $159.73 | |||||||||||
| 7 | Nov 2025 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 10 | NOS | $7.99 | $79.86 | BANGALORE AIR | NEVIS | AIR | |
| 8 | Nov 2025 | UNKNOWN BUYER | Saint Kitts and Nevis | Powder | 10 | NOS | $7.99 | $79.86 | BANGALORE AIR | NEVIS | AIR |
| SUPPLIER #4 — MYGENIC HEALTHCARE PVT LTD · 1 shipments · $39.86 | |||||||||||
| 9 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 500 | NOS | $0.080 | $39.86 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 43 Indian bleomycin exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped bleomycin in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | METINA PHARMACEUTICALS PVT LTD | NAVI MUMBAI | 1 | $108K | powder for solution | Europe |
| 2 | VENUS REMEDIES LTD | Behra | 5 | $69K | Powder, powder for solution, Injection | Americas, Europe |
| 3 | KHANDELWAL LABORATORIES PVT LTD | THANE | 4 | $38K | Injection, lyophilized powder, Vial | Asia |
| 4 | PNT PHARMA | MUMBAI | 1 | $9K | Injection | Africa |
| 5 | HEALTHBIOTICS PVT LTD | VALLABH VIDHYA NAGAR | 1 | $8K | Injection | Africa |
| 6 | GETWELL PHARMA INDIA PVT LTD | GURGAON | 5 | $7K | Injection | Africa |
| 7 | AARIA PHARMACEUTICALS PVT LTD | VADODARA | 1 | $6K | Injection | Africa |
| 8 | BRUCK PHARMA PVT LTD | NANI | 2 | $4K | Injection | Europe, Africa |
| 9 | KWALITY PHARMACEUTICALS LTD | AMRITSAR | 1 | $4K | Injection | Europe |
| 10 | ZUVIUS LIFESCIENCES PVT LTD | GHATKOPAR (E) | 3 | $3K | Injection | Africa |
| 11 | SUBHRA PHARMA PRIAVATE LTD | Navghar Mulund East Mumbai | 4 | $2K | Vial | Africa |
| 12 | 3S CORP | MUMBAI | 5 | $2K | Injection | Asia |
| 13 | RMPL PHARMA LLP | MUMBAI | 4 | $2K | Injection | Asia |
| 14 | NIVIRA EXPORTS | MUMBAI | 2 | $1K | Injection | Americas |
| 15 | GALAXY SUPER SPECIALITY | NEW DELHI | 1 | $1K | Injection | Asia |
| 16 | SMITS HEALTHCARE | NAGPUR | 1 | $1K | Injection | Africa |
| 17 | NEOPHAR PHARMACEUTICALS PVT LTD | DELHI | 1 | $870.10 | Injection | Africa |
| 18 | ZEAL PHARMA | NEW KOSAD ROAD AMROLI | 3 | $862.31 | Injection, Other | Asia |
| 19 | SANSKRUTI PHARMA | SURAT | 5 | $770.54 | Injection | Africa |
| 20 | MEDEX PHARMACEUTICALS | KULASEKHARAM POST | 4 | $716.71 | Injection | Asia |
| 21 | G P INTERGLOBE | GURGAON | 1 | $700.69 | Injection | Africa |
| 22 | JMB PHARMACEUTICALS PVT LTD | MUMBAI | 3 | $674.62 | Injection | Asia |
| 23 | DROPS PHARMA PVT LTD | HOSDURG | 1 | $587.64 | Injection | Asia |
| 24 | MATHI ASSOCIATES | MUMBAI | 1 | $543.34 | Injection | Africa |
| 25 | PIRZE LIFECARE PVT LTD | AHMEDABAD | 1 | $357.99 | Africa | |
| 26 | PHARMA CHOICE LLP | MULUND EAST | 1 | $317.36 | Injection | Asia |
| 27 | ZAHIDI ENTERPRISE | CHINCHBUNDER | 1 | $287.17 | Injection | Africa |
| 28 | RUN MEDWAY | SURAT | 1 | $280.48 | Injection | Africa |
| 29 | NEON LABORATORIES LTD | ANDHERI EAST | 4 | $219.00 | Injection, Vial | Asia |
| 30 | SPR ONCOCARE PVT LTD | BANGALORE | 2 | $159.73 | Powder | Americas |
| 31 | DM WORLDWIDE TRADING | MAHESANA | 1 | $156.75 | Injection | Africa |
| 32 | VANDAN HEALTHCARE | AHMEDABAD | 1 | $152.83 | Injection | Asia |
| 33 | PREMIER ENTERPRISE | NAGPUR | 1 | $99.89 | Injection | Africa |
| 34 | RUTVA MEDICARE | SURAT | 1 | $91.84 | Africa | |
| 35 | MC PHARMA DISTRIBUTORS | CHENNAI | 1 | $90.06 | Injection | Asia |
| 36 | HUMANKIND PHARMA | Mumbai | 1 | $84.01 | Injection | Asia |
| 37 | AL-ROYAL PHARMACEUTICAL PVT LTD | NEW DELHI | 1 | $56.37 | Injection | Africa |
| 38 | MYGENIC HEALTHCARE PVT LTD | NAVI MUMBAI | 1 | $39.86 | Injection | Americas |
| 39 | AMARI TRADE ALLIANCE LLP | MUMBAI | 2 | $20.58 | Injection | Asia |
| 40 | MATU INTERNATIONAL PVT LTD | NEW DELHI | 1 | $9.26 | Injection | Africa |
| 41 | REGALIA LIFE SCIENCE PVT LTD | PUNE | 1 | $5.36 | Vial | Asia |
| 42 | MEDYRA PHARMACEUTICAL | DELHI | 1 | $4.43 | Injection | Africa |
| 43 | VAMA HEALTH WORLD LLP | Mumbai | 1 | $0.992 | Injection | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 34 global bleomycin importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian bleomycin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | U T S D C | Mexico | 2 | $41K | VENUS REMEDIES LTD | powder for solution, Injection |
| 2 | NI LAY NAING CO LTD | Myanmar | 2 | $24K | KHANDELWAL LABORATOR… | Injection, Vial |
| 3 | F X S | Chile | 1 | $18K | VENUS REMEDIES LTD | Powder |
| 4 | P D I E | North Macedonia | 1 | $10K | VENUS REMEDIES LTD | Powder |
| 5 | TO THE | Rwanda | 1 | $9K | PNT PHARMA | Injection |
| 6 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | 4 | $7K | GETWELL PHARMA INDIA… | Injection |
| 7 | DITA ESTFARM LLC | Moldova | 1 | $4K | KWALITY PHARMACEUTIC… | Injection |
| 8 | DOMAKS INVESTMENT LTD | Nigeria | 2 | $2K | ZUVIUS LIFESCIENCES … | Injection |
| 9 | TRIDENT HEALTHCARE LTD | Mauritius | 1 | $1K | SMITS HEALTHCARE | Injection |
| 10 | FOR THE ORDER OF | United Arab Emirates | 3 | $968.62 | 3S CORP | Injection |
| 11 | HELENA SIQUEIRA PIROVANI | Brazil | 1 | $740.00 | NIVIRA EXPORTS | Injection |
| 12 | EMANUELLE GAMA RIBEIRO DO VALLE | Brazil | 1 | $740.00 | NIVIRA EXPORTS | Injection |
| 13 | HEALTH CARE AGENCY | Seychelles | 1 | $700.69 | G P INTERGLOBE | Injection |
| 14 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | 1 | $674.62 | JMB PHARMACEUTICALS … | Injection |
| 15 | M O H | Bahamas | 1 | $665.53 | VENUS REMEDIES LTD | powder for solution for injection |
| 16 | MEDIMART DRUG STORE | United Arab Emirates | 1 | $587.64 | DROPS PHARMA PVT LTD | Injection |
| 17 | BEST INTERNATIONAL FZE | United Arab Emirates | 3 | $574.95 | MEDEX PHARMACEUTICALS | Injection |
| 18 | PHARMACHEIME LTD | Malawi | 1 | $543.34 | MATHI ASSOCIATES | Injection |
| 19 | CENTRAIMED | Equatorial Guinea | 1 | $357.99 | PIRZE LIFECARE PVT LTD | |
| 20 | RADEEP SERVICES | Singapore | 1 | $317.36 | PHARMA CHOICE LLP | Injection |
| 21 | SALAMA NIGERIA LTD | Benin | 1 | $287.17 | ZAHIDI ENTERPRISE | Injection |
| 22 | CLYZ PHARMA SARL | Cameroon | 1 | $280.48 | RUN MEDWAY | Injection |
| 23 | DRUGSTORE 3U S.A | Lebanon | 2 | $216.06 | NEON LABORATORIES LTD | Injection |
| 24 | PSG EXPRESS LINK LTD | Ghana | 1 | $99.89 | PREMIER ENTERPRISE | Injection |
| 25 | STATE TRADING ORGANIZATION PLC | Maldives | 1 | $90.06 | MC PHARMA DISTRIBUTORS | Injection |
| 26 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 1 | $84.01 | HUMANKIND PHARMA | Injection |
| 27 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 1 | $79.86 | SPR ONCOCARE PVT LTD | |
| 28 | ROYAL PHARMA COMPANY | Egypt | 1 | $56.37 | AL-ROYAL PHARMACEUTI… | Injection |
| 29 | ABU ABDU | Turkey | 2 | $20.58 | AMARI TRADE ALLIANCE… | Injection |
| 30 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | 1 | $5.36 | REGALIA LIFE SCIENCE… | Vial |
| 31 | EXPTRANS GMBH | Lebanon | 2 | $2.94 | NEON LABORATORIES LTD | Injection, Vial |
| 32 | AS PER INVOICE GHANA | Ghana | 1 | $0.992 | VAMA HEALTH WORLD LLP | Injection |
| 33 | HANITRA RAZAOARIMANANA | Madagascar | 1 | $0.865 | GETWELL PHARMA INDIA… | Injection |
| 34 | MEDITERRENEAN PHARMACEUTICAL | Lebanon | 1 | $0.0000 | KHANDELWAL LABORATOR… | lyophilized powder |
This report covers 84 2025-Q4 Bleomycin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/bleomycin
Talk to our trade analyst
Need a custom bleomycin report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/bleomycin
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Bleomycin product page
Live data, supplier directory, price trends, and trade route analysis